Literature DB >> 17401566

Outcome of patients with arthritis and parvovirus B19 DNA in synovial membranes.

Simone Schmid1, Walter Bossart, Beat A Michel, Pius Brühlmann.   

Abstract

To investigate the follow-up of the 17 patients during the period of 1995-2001 of the outpatient Clinic for Rheumatology at the University Hospital of Zurich with arthritis and the presence of parvovirus B19 DNA demonstrated by PCR in synovial biopsies. Seventeen patients of 163 with arthritis, which were routinely examined by needle arthroscopy during 1995-2001 with a positive parvovirus B19 DNA by PCR of synovial biopsy were reevaluated. Investigations included medical history, clinical examination and blood tests. Joint fluid was taken on patients with joint effusion. The observation period of the 17 patients (F:M = 11:6) was 2-8 years (Ø = 6.5 years). In 8 of 17 patients the arthritis could not be classified neither at entry nor during the follow up of the study. The arthritis could be diagnosed in six patients early in the onset of the disease and included three cases of lyme arthritis of the knee joint, two cases with arthritis following a gastrointestinal infection (one with Salmonella typhimurium--positive faecal test--and the other one with a culture negative agent), one patient probably had an infection-associated arthritis after a gastrointestinal infection with Entamöeba histolytica (Schirmer et al. in Rheumatol Int 18:37-38, 1998; Kasliwal in Am J Proctol Gastroenterol Colon Rectal Surg 32:12, 16, 28, 1981; Haslock and Wright in J R Coll Phys Lond 8:1554-162, 1974; Than-Saw et al. in Trop Geogr Med 44:355-358, 1992) with remission after antibiotic therapy. After a disease course of 9 months one patient could be classified as rheumatoid arthritis in the presence of anti-cyclic citrullinated antibodies but lack of rheumatoid factor. One patient with polyarthritis developed psoriasis of the skin 22 months later. From the nine patients with unclassified arthritis 4 (45%) got into complete remission with no symptoms or signs of joint inflammation after a disease course of 9-45 months, whereas 5 (55%) still demonstrate active non erosive arthritis (disease duration between 3 and 10 years). The presence of parvovirus B19 DNA in synovial tissue of patients with joint inflammation does not allow the diagnosis of parvovirus induced arthritis. If the arthritis remains unclassified and without erosions over time a virus associated aetiology may be assumed. However, no definitive diagnosis is possible even in the presence of parvovirus B19 DNA in synovial tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401566     DOI: 10.1007/s00296-007-0337-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  25 in total

1.  Parvovirus B19 and erosive polyarthritis.

Authors:  A Tyndall; W Jelk; H H Hirsch
Journal:  Lancet       Date:  1994-02-19       Impact factor: 79.321

2.  Human parvovirus infection in early rheumatoid and inflammatory arthritis.

Authors:  B J Cohen; M M Buckley; J P Clewley; V E Jones; A H Puttick; R K Jacoby
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

3.  Transient rheumatoid factor positivity in acute human parvovirus B19 infection.

Authors:  S J Naides; E H Field
Journal:  Arch Intern Med       Date:  1988-12

4.  Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience.

Authors:  S J Naides; L L Scharosch; F Foto; E J Howard
Journal:  Arthritis Rheum       Date:  1990-09

5.  Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens.

Authors:  J P Clewley
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

6.  [Parvovirus B19-induced arthritis/arthropathy--an important differential diagnosis of chronic polyarthritis].

Authors:  T Stoll; P Brühlmann; U Brunner; A Treier; P Cassinotti; B A Michel
Journal:  Schweiz Med Wochenschr       Date:  1995-02-25

7.  Chronic colitis and arthritis with special emphasis on amoebic colitis.

Authors:  R M Kasliwal
Journal:  Am J Proctol Gastroenterol Colon Rectal Surg       Date:  1981-08

8.  A study of the role of parvovirus B19 in rheumatoid arthritis.

Authors:  J R Kerr; J P Cartron; M D Curran; J E Moore; J R Elliott; R A Mollan
Journal:  Br J Rheumatol       Date:  1995-09

9.  Persistence of parvovirus B19 in synovial fluid and bone marrow.

Authors:  S Nikkari; A Roivainen; P Hannonen; T Möttönen; R Luukkainen; T Yli-Jama; P Toivanen
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

Review 10.  Isolation of Entamoeba histolytica from arthritic knee joint.

Authors:  M M Oo; K M Win; K M Naing; Y Kaneda; T Tanaka
Journal:  Trop Geogr Med       Date:  1992-10
View more
  2 in total

Review 1.  Utility of synovial biopsy.

Authors:  Stefan Vordenbäumen; Leo Ab Joosten; Johannes Friemann; Matthias Schneider; Benedikt Ostendorf
Journal:  Arthritis Res Ther       Date:  2009-11-23       Impact factor: 5.156

2.  Detection of parvovirus B19 in selected high-risk patient groups & their phylogenetic & selection analysis.

Authors:  Kumaran Vadivel; Ramamurthy Mageshbabu; Sathish Sankar; Amita Jain; Vivekanandan Perumal; Padma Srikanth; Ghosh Asit Ranjan; Aravindan Nair; Eric A F Simoes; Balaji Nandagopal; Gopalan Sridharan
Journal:  Indian J Med Res       Date:  2018-04       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.